FTG.TO vs. RXRX
FTG.TO (Firan Technology Group Corporation) and RXRX (Recursion Pharmaceuticals, Inc.) are both stocks. FTG.TO operates in Aerospace & Defense (Industrials), while RXRX operates in Biotechnology (Healthcare). Over the past 5 years, FTG.TO returned 52.56%/yr vs -32.92%/yr for RXRX. At a 0.15 correlation, their price movements are largely independent.
Performance
FTG.TO vs. RXRX - Performance Comparison
Loading charts...
Different Trading Currencies
FTG.TO is traded in CAD, while RXRX is traded in USD. To make them comparable, the RXRX values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, FTG.TO achieves a 111.08% return, which is significantly higher than RXRX's -14.08% return.
FTG.TO
- 1D
- -0.97%
- 1M
- 18.46%
- YTD
- 111.08%
- 6M
- 117.68%
- 1Y
- 130.00%
- 3Y*
- 94.57%
- 5Y*
- 52.56%
- 10Y*
- 24.71%
RXRX
- 1D
- -3.48%
- 1M
- 0.55%
- YTD
- -14.08%
- 6M
- -25.82%
- 1Y
- -19.94%
- 3Y*
- -24.14%
- 5Y*
- -32.92%
- 10Y*
- —
FTG.TO vs. RXRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
FTG.TO Firan Technology Group Corporation | 111.08% | 58.44% | 71.53% | 80.85% | -11.32% | 14.22% |
RXRX Recursion Pharmaceuticals, Inc. | -14.08% | -42.27% | -25.55% | 25.07% | -51.78% | -44.68% |
Correlation
The correlation between FTG.TO and RXRX is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Apr 19, 2021 | 0.15 |
Fundamentals
FTG.TO:
CA$620.33M
RXRX:
$1.84B
FTG.TO:
CA$0.53
RXRX:
-$1.17
FTG.TO:
3.16
RXRX:
25.13
FTG.TO:
6.31
RXRX:
1.79
FTG.TO:
CA$195.62M
RXRX:
$66.29M
FTG.TO:
CA$62.70M
RXRX:
-$22.83M
FTG.TO:
CA$31.24M
RXRX:
-$505.90M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTG.TO vs. RXRX — Risk / Return Rank
FTG.TO
RXRX
FTG.TO vs. RXRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Firan Technology Group Corporation (FTG.TO) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FTG.TO | RXRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.91 | ||
| Sortino ratioReturn per unit of downside risk | +3.03 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.01 | +0.38 |
| Calmar ratioReturn relative to maximum drawdown | 5.79 | -0.34 | +6.13 |
| Martin ratioReturn relative to average drawdown | 13.37 | -0.56 | +13.92 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FTG.TO | RXRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.64 | -0.27 | +2.91 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.26 | -0.36 | +1.62 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.55 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | -0.36 | +0.32 |
Drawdowns
FTG.TO vs. RXRX - Drawdown Comparison
The maximum FTG.TO drawdown since its inception was -99.96%, which is greater than RXRX's maximum drawdown of -92.43%. Use the drawdown chart below to compare losses from any high point for FTG.TO and RXRX.
Loading charts...
Drawdown Indicators
| FTG.TO | RXRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.96% | -92.43% | -7.53% |
Max Drawdown (1Y)Largest decline over 1 year | -22.58% | -58.91% | +36.33% |
Max Drawdown (3Y)Largest decline over 3 years | -24.88% | -81.34% | +56.46% |
Max Drawdown (5Y)Largest decline over 5 years | -47.21% | -92.43% | +45.22% |
Max Drawdown (10Y)Largest decline over 10 years | -68.78% | — | — |
Current DrawdownCurrent decline from peak | -94.70% | -90.68% | -4.02% |
Average DrawdownAverage peak-to-trough decline | -91.08% | -74.12% | -16.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.76% | 35.76% | -26.00% |
Volatility
FTG.TO vs. RXRX - Volatility Comparison
The current volatility for Firan Technology Group Corporation (FTG.TO) is 16.86%, while Recursion Pharmaceuticals, Inc. (RXRX) has a volatility of 18.61%. This indicates that FTG.TO experiences smaller price fluctuations and is considered to be less risky than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTG.TO | RXRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.86% | 18.61% | -1.75% |
Volatility (6M)Calculated over the trailing 6-month period | 39.45% | 44.48% | -5.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.64% | 73.00% | -23.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.34% | 92.52% | -50.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.18% | 92.67% | -47.49% |
Dividends
FTG.TO vs. RXRX - Dividend Comparison
Neither FTG.TO nor RXRX has paid dividends to shareholders.
Financials
FTG.TO vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between Firan Technology Group Corporation and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
FTG.TO and RXRX have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for FTG.TO and RXRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer